Nanopacli 100 mg Injection
$82.23
$64.41
Nanopacli 100 mg injection is an innovative microtubule inhibitor designed for the treatment of metastatic breast cancer in patients who have not responded to combination chemotherapy or have experienced a relapse within six months after adjuvant chemotherapy. Additionally, this powerful medication can be used alongside carboplatin as a first-line therapeutic option for individuals with locally advanced or metastatic non-small cell lung cancer who are not candidates for radical surgery or radiation treatments. For those battling metastatic pancreatic cancer, Nanopacli is also effective when combined with gemcitabine as an initial therapy. It is essential for patients to be aware of potential side effects and to discuss their medical history with their healthcare provider prior to starting treatment. The formulation of Nanopacli enhances its efficacy while aiming to minimize adverse reactions, making it a vital option in the oncological arsenal. Always consult with your oncologist to determine if Nanopacli is the right choice for your specific cancer treatment plan. This medication represents a significant advancement in the management of complex cancer cases, contributing to improved outcomes for patients facing difficult diagnoses.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Nanopacli 100 mg injection is utilized in the treatment of metastatic breast cancer, a condition where cancer cells have spread beyond the breast to other organs like the bones and liver. This medication helps to inhibit the growth of cancer cells, potentially improving patient outcomes. It is often part of a comprehensive treatment plan to manage advanced stages of breast cancer. Regular monitoring and assessment are essential to determine its effectiveness.
• In the case of Non-Small Cell Lung Cancer (NSCLC), Nanopacli 100 mg injection is employed to target cancer that originates in the lung tissues. NSCLC can lead to various symptoms, including persistent coughing and chest discomfort. By using this injection, healthcare providers aim to reduce tumor size and slow disease progression. Patients may receive this treatment in combination with other therapies to enhance overall efficacy.
• Nanopacli 100 mg injection is indicated for the treatment of ovarian cancer, which often remains asymptomatic in its early stages. This medication plays a crucial role in managing advanced ovarian cancer by disrupting the growth of malignant cells. As symptoms may become more pronounced with disease advancement, timely intervention with Nanopacli can be critical for improving quality of life. Physicians often consider this treatment as part of a multi-faceted approach to cancer care.
• For pancreatic adenocarcinoma, Nanopacli 100 mg injection serves as an important therapeutic option. This form of cancer typically presents with vague symptoms that may not become apparent until later stages. By administering Nanopacli, clinicians aim to target the cancerous cells in the pancreas, potentially leading to better management of the disease. Continuous evaluation of treatment response is vital for optimizing patient care during therapy.
Benefits
Nanopacli 100 mg Injection is an anticancer medicine that is used to treat many types of cancer, which include breast cancer, lung cancer, ovarian cancer, and pancreatic cancer.it's known to be efficient in treating different types of cancer either alone or in a mixture with other chemotherapy medications or radiation therapy. Nanopacli 100 mg interfering with the division of cancer cells, kills or stops the growth of cancer cells and prevents the multiplication of cancer cells and relieves the symptoms of breast cancer and stomach cancer. Nanopacli Anti-Cancer Drug can improve overall survival and disease-free survival in patients with HER2-positive breast cancer when used in combination with other cancer treatments.
Side Effects
Like all medications, Nanopacli for Breast Cancer can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Hair loss
• Peripheral neuropathy
• Abnormal ECG
• Low blood count
• Nausea
• Vomiting
• Diarrhoea
• Loss of appetite
• Arthralgia ( joint pain)
• Myalgia (muscle pain)
• Mouth sores
• Headache
Common Side Effects
• Irregular Heartbeats ( Tachycardia/Bradycardia)
• Vision changes
• Bleeding
• Dizziness
• Vision changes
How To Use
Nanopacli Anti-Cancer Drug is an intravenous infusion, administered by a healthcare professional or nurse in a hospital or clinic setting. The specific dosing and administration of the Nanopacli 100 mg Injection will be determined by the patient's clinical condition, age, medical history, type of cancer and other factors. It is important to note that this Nanopacli 100 mg should not be self-administered, and it is important to follow the instructions of the healthcare professional administering the Nanopacli 100 mg Injection.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Nanopacli 100 mg. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Nanopacli 100 mg Injection is safe to use in patients with kidney disease. No dose adjustment of Nanopacli 100 mg is recommended. If you experience any side effects please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Nanopacli 100 mg Injection. Nanopacli 100mg Vial may pass into breast milk and harm the infant. If you are breastfeeding and taking Nanopacli 100 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Nanopacli 100 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Nanopacli 100 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Albumin-bound Paclitaxel Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Nanopacli 100 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Nanopacli 100mg Vial during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Nanopacli 100 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Albumin-bound Paclitaxel Injection.